PyL

Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results
BioSpace
Mon, 12/23/19 - 11:48 pm
Progenics Pharmaceuticals
prostate cancer
PyL
cancer imaging
diagnostics